Humboldt Fund (Humboldt Ventures) is a venture capital fund that supports innovative, early-stage companies by investing in the biotech revolution. Synthetic biology is poised to transform the way we make chemicals, materials, foods and medicines. At Humboldt Fund, we identify and invest in pioneers of engineering, physical sciences and life sciences to bring emerging biotech enterprises to a global market. Together we explore, discover and create new technologies that disrupt global conventions and solve the critical issues of our world, while creating value and prosperity.
Company Details
- Employees
- 4
- Address
- 477 Madison Ave,
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://humboldtfund.com/
- Keywords
- Show more similar pages.
- HQ
- New York
Humboldt Fund Questions
Humboldt Fund's website is https://humboldtfund.com/
Humboldt Fund's LinkedIn profile is https://www.linkedin.com/company/humboldt-fund
Humboldt Fund has
4 employees.
View email and phone details for 4
employees at Humboldt Fund.
Humboldt Fund's industry is
Venture Capital and Private Equity Principals
Humboldt Fund's top competitors are
Metagenomi,
Momentum Therapeutics,
Celta Inversiones Spa,
Posterus Partners,
Vega Group,
Haya Therapeutics,
Droia Ventures,
Meatable,
Khora Therapeutics,
Phagelab.
Humboldt Fund's categories are Venture Capital and Private Equity Principals
